Learning Center

SIBIONICS CGM learning center provides the latest global guidelines, clinical consensus, and research to help healthcare professionals and people with diabetes understand CGM principles, applications, and data interpretation.

<p>International Diabetes Federation Position Statement on the 1-hour post-load plasma glucose for the diagnosis of intermediate hyperglycaemia and type 2 diabetes</p>

International Diabetes Federation Position Statement on the 1-hour post-load plasma glucose for the diagnosis of intermediate hyperglycaemia and type 2 diabetes

<p>International Consensus on Use of Continuous Glucose Monitoring</p>

International Consensus on Use of Continuous Glucose Monitoring

<p>Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range</p>

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

<p>Clinical application guideline for blood glucose monitoring in China (2021 edition)</p>

Clinical application guideline for blood glucose monitoring in China (2021 edition)

<p>Standards of Care in Diabetes—2026</p>

Standards of Care in Diabetes—2026

<p>Clinical performance evaluation of the SiJoy GS1 continuous glucose monitor during oral glucose tolerance testing in healthy adults</p>

Clinical performance evaluation of the SiJoy GS1 continuous glucose monitor during oral glucose tolerance testing in healthy adults

<p>Evaluation of the performance and usability of a novel continuous glucose monitoring system</p>

Evaluation of the performance and usability of a novel continuous glucose monitoring system

<p>Clinical assessment and acceptance criteria for continuous glucose monitoring (CGM) system performance: A proposed guideline by the IFCC Working Group on CGM</p>

Clinical assessment and acceptance criteria for continuous glucose monitoring (CGM) system performance: A proposed guideline by the IFCC Working Group on CGM

<p>Continuous glucose monitoring and metrics for clinical trials: an international consensus statement</p>

Continuous glucose monitoring and metrics for clinical trials: an international consensus statement

<p>Expert consensus on the clinical application of continuous glucose monitoring in primary care (2025)</p>

Expert consensus on the clinical application of continuous glucose monitoring in primary care (2025)

<p>Expert consensus for clinical application of continuous glucose monitoring (2024)</p>

Expert consensus for clinical application of continuous glucose monitoring (2024)

Expert consensus on nursing applications of ambulatory glucose profile report (2025 edition)

<p>Minimum expectations for market authorization of continuous glucose monitoring devices in Europe—‘eCGM’ compliance status</p>

Minimum expectations for market authorization of continuous glucose monitoring devices in Europe—‘eCGM’ compliance status

<p>Guideline for the prevention and treatment of diabetes mellitus in China (2024 edition)</p>

Guideline for the prevention and treatment of diabetes mellitus in China (2024 edition)

Expert consensus on the clinical application of ambulatory glucose profile report (2023 edition)

Disclaimers

The pictures and images are for illustration purpose only, and may differ in appearance from the actual product.

The CGM System is intended to be used by patients：

①3 years and older with Type 1 or Type 2 Diabetes Mellitus in select countries

②18 years and older with Type 1 or Type 2 Diabetes Mellitus in other countries

For country-specific indications, please contact: support@sibionics.com

δ MARD(Mean Absolute Relative Difference) is a standard way to measure CGM accuracy. For the CGM system, the MARD value is 8.7% in children and adolescents aged 3–17, and 8.83% in adults aged 18 and older.

▫The Sensor is water-resistant and can be worn while bathing, showering, or swimming. Note:DO NOT immerse the Sensor deeper than 1 meter (3 feet) or for longer than 1 hour.

₼Do a blood glucose test if you think your glucose readings are not correct or do not match how you feel. Do not ignore symptoms that may be due to low or high glucose.ǁKeep the Sensor and display device within 6 meters (20 feet) with no obstacles (such as walls or metal) between them, otherwise communication may be compromised.

ΔTo receive alarms, the App needs to be operating in the background.

◊◊The SIBIONICS app stores the last 90 days of your glucose data. For glucose data older than 90 days, please contact our customer support team.

♮The smartphone app runs on both Android and Apple smart devices. For supported smart devices, go to https://www.sibionicscgm.com/pages/mobile-device-compatibility.

ღThe initial activation requires scanning, after that, glucose reading is updated every 5 minutes via Bluetooth.

☽Readings will start being performed after the 1-hour Sensor warm-up has passed.

◁Invite a friend to view your sensor glucose readings and trending graphs, or follow other’s glucose readings and trends.

‥ AGP(Ambulatory Glucose Profile) needs at least 5 days of glucose data.

※Work with your professional healthcare team to put together a plan for managing your diabetes that includes when to use the CGM System information for making treatment decisions.

◑The CGM System must be removed prior to MRI, X-ray examination, CT scan, or diathermy treatment.

SIBIONICS CGM Learning Center | Latest & Professional

Net Orders Checkout

Item		Price	Qty	Total
		Subtotal	€0,00
		Shipping
		Total

Shipping Address

Shipping Methods